Natural Antisense Transcript for Hyaluronan Synthase 2 (HAS2-AS1) Induces Transcription of HAS2 via Protein O-GlcNAcylation*

Background: Intracellular proteins glycosylation with O-GlcNAc is able to influence cell microenvironment. Results: O-GlcNAcylation increases hyaluronan synthase 2 (HAS2) transcription via its natural antisense transcript HAS2-AS1. Conclusion: A novel mechanism to regulate hyaluronan synthesis via long non-coding RNA is described. Significance: This finding highlights a new target to regulate HA synthesis, critical in many pathophysiological processes. Changes in the microenvironment organization within vascular walls are critical events in the pathogenesis of vascular pathologies, including atherosclerosis and restenosis. Hyaluronan (HA) accumulation into artery walls supports vessel thickening and is involved in many cardiocirculatory diseases. Excessive cytosolic glucose can enter the hexosamine biosynthetic pathway, increase UDP-N-acetylglucosamine (UDP-GlcNAc) availability, and lead to modification of cytosolic proteins via O-linked attachment of the monosaccharide β-N-GlcNAc (O-GlcNAcylation) from UDP-GlcNAc by the enzyme O-GlcNAc transferase. As many cytoplasmic and nuclear proteins can be glycosylated by O-GlcNAc, we studied whether the expression of the HA synthases that synthesize HA could be controlled by O-GlcNAcylation in human aortic smooth muscle cells. Among the three HAS isoenzymes, only HAS2 mRNA increased after O-GlcNAcylation induced by glucosamine treatments or by inhibiting O-GlcNAc transferase with PUGNAC (O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate). We found that the natural antisense transcript of HAS2 (HAS2-AS1) was absolutely necessary to induce the transcription of the HAS2 gene. Moreover, we found that O-GlcNAcylation modulated HAS2-AS1 promoter activation by recruiting the NF-κB subunit p65, but not the HAS2 promoter, whereas HAS2-AS1 natural antisense transcript, working in cis, regulated HAS2 transcription by altering the chromatin structure around the HAS2 proximal promoter via O-GlcNAcylation and acetylation. These results indicate that HAS2 transcription can be finely regulated not only by recruiting transcription factors to the promoter as previously described but also by modulating chromatin accessibility by epigenetic modifications.

[1]  Kotb Abdelmohsen,et al.  Posttranscriptional gene regulation by long noncoding RNA. , 2013, Journal of molecular biology.

[2]  D. Vigetti,et al.  Vascular Pathology and the Role of Hyaluronan , 2008, TheScientificWorldJournal.

[3]  Jeannie T. Lee.  Epigenetic Regulation by Long Noncoding RNAs , 2012, Science.

[4]  K. Törrönen,et al.  Regulation of the Hyaluronan Synthase 2 Gene by Convergence in Cyclic AMP Response Element-binding Protein and Retinoid Acid Receptor Signaling* , 2009, The Journal of Biological Chemistry.

[5]  G. Hart,et al.  O-GlcNAc signaling: a metabolic link between diabetes and cancer? , 2010, Trends in biochemical sciences.

[6]  Y. Yamaguchi,et al.  Overexpression of Hyaluronan in the Tunica Media Promotes the Development of Atherosclerosis , 2005, Circulation research.

[7]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[8]  P. Noble,et al.  Hyaluronan as an immune regulator in human diseases. , 2011, Physiological reviews.

[9]  Andrew J. Bannister,et al.  Regulation of chromatin by histone modifications , 2011, Cell Research.

[10]  H. Chao,et al.  Natural Antisense mRNAs to Hyaluronan Synthase 2 Inhibit Hyaluronan Biosynthesis and Cell Proliferation* , 2005, Journal of Biological Chemistry.

[11]  D. Vigetti,et al.  Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Gerald W. Hart,et al.  O-GlcNAc signalling: implications for cancer cell biology , 2011, Nature Reviews Cancer.

[13]  P. Bornstein,et al.  Glycosylation Mediates Up-regulation of a Potent Antiangiogenic and Proatherogenic Protein, Thrombospondin-1, by Glucose in Vascular Smooth Muscle Cells* , 2007, Journal of Biological Chemistry.

[14]  V. Hascall,et al.  The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells. , 2009, Glycobiology.

[15]  D. Vigetti,et al.  Hyaluronan: biosynthesis and signaling. , 2014, Biochimica et biophysica acta.

[16]  M. Tammi,et al.  Transcriptional and post‐translational regulation of hyaluronan synthesis , 2011, The FEBS journal.

[17]  D. Rader,et al.  The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. , 2001, The Journal of clinical investigation.

[18]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[19]  Vladimir Petrovic,et al.  Forkhead Box M1 Regulates the Transcriptional Network of Genes Essential for Mitotic Progression and Genes Encoding the SCF (Skp2-Cks1) Ubiquitin Ligase , 2005, Molecular and Cellular Biology.

[20]  H. Nasheuer,et al.  Modification of Histones by Sugar β-N-Acetylglucosamine (GlcNAc) Occurs on Multiple Residues, Including Histone H3 Serine 10, and Is Cell Cycle-regulated* , 2011, The Journal of Biological Chemistry.

[21]  M. Ramoni,et al.  Glycosaminoglycans and Glucose Prevent Apoptosis in 4-Methylumbelliferone-treated Human Aortic Smooth Muscle Cells* , 2011, The Journal of Biological Chemistry.

[22]  C. Wolkow,et al.  Dynamic O-GlcNAc cycling at promoters of Caenorhabditis elegans genes regulating longevity, stress, and immunity , 2010, Proceedings of the National Academy of Sciences.

[23]  G. Hart,et al.  Cellular Content of UDP-N-acetylhexosamines Controls Hyaluronan Synthase 2 Expression and Correlates with O-Linked N-Acetylglucosamine Modification of Transcription Factors YY1 and SP1* , 2011, The Journal of Biological Chemistry.

[24]  Kyong-Tai Kim,et al.  O‐GlcNAcase is essential for embryonic development and maintenance of genomic stability , 2012, Aging cell.

[25]  A. Phillips,et al.  The Human Hyaluronan Synthase 2 (HAS2) Gene and Its Natural Antisense RNA Exhibit Coordinated Expression in the Renal Proximal Tubular Epithelial Cell♦ , 2011, The Journal of Biological Chemistry.

[26]  J. Hanover,et al.  Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation , 2012, Nature Reviews Molecular Cell Biology.

[27]  G. Hart,et al.  Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. , 2008, American journal of physiology. Endocrinology and metabolism.

[28]  J. Mattick,et al.  Structure and function of long noncoding RNAs in epigenetic regulation , 2013, Nature Structural &Molecular Biology.

[29]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[30]  E. Solary,et al.  TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS , 2013, The EMBO journal.

[31]  X. Zhou,et al.  Dense Chromatin Activates Polycomb Repressive Complex 2 to Regulate H3 Lysine 27 Methylation , 2012, Science.

[32]  Emily Bernstein,et al.  RNA meets chromatin. , 2005, Genes & development.

[33]  M. Tammi,et al.  Role of UDP-N-Acetylglucosamine (GlcNAc) and O-GlcNAcylation of Hyaluronan Synthase 2 in the Control of Chondroitin Sulfate and Hyaluronan Synthesis* , 2012, The Journal of Biological Chemistry.

[34]  T. Morgan,et al.  Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase , 2008, Nature Medicine.

[35]  Xiaochun Yu,et al.  TET2 promotes histone O-GlcNAcylation during gene transcription , 2012, Nature.

[36]  V. Hascall,et al.  Molecular Cloning and Characterization of UDP-glucose Dehydrogenase from the Amphibian Xenopus laevis and Its Involvement in Hyaluronan Synthesis* , 2006, Journal of Biological Chemistry.

[37]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[38]  Howard Y. Chang,et al.  Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.

[39]  D. Vigetti,et al.  Metabolic control of hyaluronan synthases. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[40]  Sreenath S. Andrali,et al.  Modulation of transcription factor function by O-GlcNAc modification. , 2010, Biochimica et biophysica acta.

[41]  Gerald W. Hart,et al.  Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.

[42]  V. Hascall,et al.  Hyaluronan Synthesis Is Inhibited by Adenosine Monophosphate-activated Protein Kinase through the Regulation of HAS2 Activity in Human Aortic Smooth Muscle Cells* , 2011, The Journal of Biological Chemistry.

[43]  V. Hascall,et al.  Proinflammatory Cytokines Induce Hyaluronan Synthesis and Monocyte Adhesion in Human Endothelial Cells through Hyaluronan Synthase 2 (HAS2) and the Nuclear Factor-κB (NF-κB) Pathway* , 2010, The Journal of Biological Chemistry.

[44]  C. Allis,et al.  Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers , 2010, Nature Reviews Cancer.

[45]  Zhen Su,et al.  Integrative genomic analyses reveal clinically relevant long non-coding RNA in human cancer , 2013 .

[46]  C. Wahlestedt,et al.  Regulatory roles of natural antisense transcripts , 2009, Nature Reviews Molecular Cell Biology.

[47]  V. Raghavan.  Insulin resistance and atherosclerosis. , 2012, Heart failure clinics.

[48]  G. Hart,et al.  Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-κB acetylation and transcription , 2012, Proceedings of the National Academy of Sciences.

[49]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[50]  E. Kang,et al.  NFκB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions , 2008, Proceedings of the National Academy of Sciences.

[51]  D. Männel,et al.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.

[52]  J. Isner,et al.  Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. , 1996, Circulation.

[53]  M. Buse.  Hexosamines, insulin resistance, and the complications of diabetes: current status. , 2006, American journal of physiology. Endocrinology and metabolism.

[54]  M. Shannon,et al.  Chromatin Remodeling, Measured by a Novel Real-Time Polymerase Chain Reaction Assay, Across the Proximal Promoter Region of the IL-2 Gene , 2001, The Journal of Immunology.

[55]  G. Hart,et al.  β-N-acetylglucosamine (O-GlcNAc) is part of the histone code , 2010, Proceedings of the National Academy of Sciences.

[56]  C. Wahlestedt,et al.  Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. , 2012, Trends in genetics : TIG.